Literature DB >> 18936330

Basic control of reperfusion effectively protects against reperfusion injury in a realistic rodent model of acute limb ischemia.

Florian Dick1, Jianhui Li, Marie-Noëlle Giraud, Christoph Kalka, Juerg Schmidli, Hendrik Tevaearai.   

Abstract

BACKGROUND: Reperfusion injury is insufficiently addressed in current clinical management of acute limb ischemia. Controlled reperfusion carries an enormous clinical potential and was tested in a new reality-driven rodent model. METHODS AND
RESULTS: Acute hind-limb ischemia was induced in Wistar rats and maintained for 4 hours. Unlike previous tourniquets models, femoral vessels were surgically prepared to facilitate controlled reperfusion and to prevent venous stasis. Rats were randomized into an experimental group (n=7), in which limbs were selectively perfused with a cooled isotone heparin solution at a limited flow rate before blood flow was restored, and a conventional group (n=7; uncontrolled blood reperfusion). Rats were killed 4 hours after blood reperfusion. Nonischemic limbs served as controls. Ischemia/reperfusion injury was significant in both groups; total wet-to-dry ratio was 159+/-44% of normal (P=0.016), whereas muscle viability and contraction force were reduced to 65+/-13% (P=0.016) and 45+/-34% (P=0.045), respectively. Controlled reperfusion, however, attenuated reperfusion injury significantly. Tissue edema was less pronounced (132+/-16% versus 185+/-42%; P=0.011) and muscle viability (74+/-11% versus 57+/-9%; P=0.004) and contraction force (68+/-40% versus 26+/-7%; P=0.045) were better preserved than after uncontrolled reperfusion. Moreover, subsequent blood circulation as assessed by laser Doppler recovered completely after controlled reperfusion but stayed durably impaired after uncontrolled reperfusion (P=0.027).
CONCLUSIONS: Reperfusion injury was significantly alleviated by basic modifications of the initial reperfusion period in a new in vivo model of acute limb ischemia. With this model, systematic optimizations of according protocols may eventually translate into improved clinical management of acute limb ischemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936330     DOI: 10.1161/CIRCULATIONAHA.108.787754

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Electro-Acupuncture on ST36 and SP6 Acupoints Ameliorates Lung Injury via Sciatic Nerve in a Rat Model of Limb Ischemia-Reperfusion.

Authors:  Wei Lin; Danyun Jia; Changchang Fu; Yihui Zheng; Zhenlang Lin
Journal:  J Inflamm Res       Date:  2020-08-24

2.  Simvastatin inhibits inflammation in ischemia-reperfusion injury.

Authors:  Yilin Zhao; Qingzhao Feng; Zhengjie Huang; Wenpeng Li; Baisheng Chen; Long Jiang; Binglin Wu; Weiji Ding; Gang Xu; Heng Pan; Wei Wei; Weiyuan Luo; Qi Luo
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 3.  Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion.

Authors:  Stéphanie Paradis; Anne-Laure Charles; Alain Meyer; Anne Lejay; James W Scholey; Nabil Chakfé; Joffrey Zoll; Bernard Geny
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-13       Impact factor: 4.249

4.  C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.

Authors:  Claudia Duehrkop; Yara Banz; Rolf Spirig; Sylvia Miescher; Marc W Nolte; Martin Spycher; Richard A G Smith; Steven H Sacks; Robert Rieben
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

5.  Oxidative stress evaluation of skeletal muscle in ischemia-reperfusion injury using enhanced magnetic resonance imaging.

Authors:  Yoshinori Kuroda; Hitoshi Togashi; Tetsuro Uchida; Kazuyuki Haga; Atsushi Yamashita; Mitsuaki Sadahiro
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

6.  Inhibition of Prostaglandin Transporter (PGT) Promotes Perfusion and Vascularization and Accelerates Wound Healing in Non-Diabetic and Diabetic Rats.

Authors:  Zhongbo Liu; Outhiriaradjou Benard; Mahrukh M Syeda; Victor L Schuster; Yuling Chi
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

7.  Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice.

Authors:  Tobias Deuse; Grigol Tediashvili; Xiaomeng Hu; Alessia Gravina; Annika Tamenang; Dong Wang; Andrew Connolly; Christian Mueller; Beñat Mallavia; Mark R Looney; Malik Alawi; Lewis L Lanier; Sonja Schrepfer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.